Colonic necrosis due to oral kayexalate in a critically-ill patient.
Author(s): Thomas A, James BR, Landsberg D
Affiliation(s): Department of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA. firstname.lastname@example.org
Publication date & source: 2009-04, Am J Med Sci., 337(4):305-6.
Publication type: Case Reports
Kayexalate (sodium polystyrene sulfonate in sorbitol) is commonly used for treatment of hyperkalemia. We describe the case of a critically ill patient who developed colonic necrosis after oral administration of kayexalate.